Henig Noreen 4
4 · Kezar Life Sciences, Inc. · Filed Jul 26, 2023
Insider Transaction Report
Form 4
Henig Noreen
Chief Medical Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2023-07-24−280,000→ 0 totalExercise: $5.45Exp: 2031-01-07→ Common Stock (280,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-07-24−180,000→ 0 totalExercise: $14.55Exp: 2032-01-04→ Common Stock (180,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-07-24−220,000→ 0 totalExercise: $6.84Exp: 2033-01-07→ Common Stock (220,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-07-24−300,000→ 0 totalExercise: $4.56Exp: 2030-04-30→ Common Stock (300,000 underlying) - Award
Employee Stock Option (right to buy)
2023-07-24+300,000→ 300,000 totalExercise: $2.28Exp: 2030-04-30→ Common Stock (300,000 underlying) - Award
Employee Stock Option (right to buy)
2023-07-24+280,000→ 280,000 totalExercise: $2.28Exp: 2031-01-07→ Common Stock (280,000 underlying) - Award
Employee Stock Option (right to buy)
2023-07-24+180,000→ 180,000 totalExercise: $2.28Exp: 2032-01-04→ Common Stock (180,000 underlying) - Award
Employee Stock Option (right to buy)
2023-07-24+220,000→ 220,000 totalExercise: $2.28Exp: 2033-01-07→ Common Stock (220,000 underlying)
Footnotes (5)
- [F1]Twenty-five percent (25%) of the shares subject to the option vested on May 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such vesting date.
- [F2]On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged.
- [F3]One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.
- [F4]One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date.
- [F5]One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date.